Details for 2017713852
Up to date per 26.05.2026
Actions
Details for 2017713852
Granted/Registered
European Patent
13.03.2019 A
26.01.2022 B1
03.05.2016
US
201662331117 P
A61M 16/08 20060101AFI20171110BHEP
Owner
Mallinckrodt Pharmaceuticals Ireland LimitedCollege Business & Technology Park Cruiserath, Blanchardstown Dublin 15IE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
BIBA, Scott, I.512 Dorn Drive Waunakee, WI 53597US
Information about Fees